亚洲日韩欧美一区久久久久,俺也去免费,国产在线vr专区,欧美图片视频一区二区,亚洲色图一区二区网址,2018国产在线精品一区二区

排名推廣
排名推廣
發(fā)布廣告
發(fā)布廣告
會員中心
會員中心
推廣 熱搜: 檢測  分析儀器  分析儀  凱氏定氮  低溫槽  烘箱  磁力攪拌器  均質(zhì)器  采樣器  超低溫冰箱 
 

利拉列汀雜質(zhì),利格列汀雜質(zhì)對照品

點擊圖片查看原圖
 
品牌: 遠揚
單價: 面議
起訂: 10 mg
供貨總量: 1000 mg
發(fā)貨期限: 自買家付款之日起 10 天內(nèi)發(fā)貨
所在地: 廣東 深圳市
有效期至: 長期有效
最后更新: 2017-03-28 17:09
瀏覽次數(shù): 419
詢價
 
公司基本資料信息
詳細說明
利拉列汀雜質(zhì),利格列汀雜質(zhì)對照品  產(chǎn)品介紹:
中文名稱:利拉列汀雜質(zhì),利格列汀雜質(zhì)對照品
英文名稱:Linagliptin Impurity
規(guī)格:10mg/25mg/50mg/100mg等多種規(guī)格可選。
用途:實驗研發(fā),藥品申報檢測,不得用于臨床醫(yī)學診斷。
隨貨提供:所有雜質(zhì)對照品均隨貨提供HPLC,NMR,MS圖譜及CoA證書。
保存及取用:為了防止產(chǎn)品含量降低,應(yīng)防潮,避光和抗氧化包裝,保存應(yīng)以提高物質(zhì)穩(wěn)定性為原則。如果一次使用很少量,可以將其適當分裝后使用,這樣可以有效的防止試劑污染。請不要在臟亂和強光環(huán)境中取用,以免造成污染和失效。

利拉列汀雜質(zhì),利格列汀雜質(zhì)對照品 雜質(zhì)列表:
Linagliptin (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione  
Linagliptin Impurity 1  7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione  
Linagliptin Impurity 2 2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide  
Linagliptin Impurity 3 (R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione N-Phthalimide-linagliptin
Linagliptin Impurity 4 (R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione Linagliptin Impurity S
Linagliptin Impurity 5 N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide  
Linagliptin Impurity 6 (R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid  
Linagliptin Impurity 7 8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1) Linagliptin Diene Impurity
Linagliptin Impurity 8 (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide Linagliptin Acetamide
Linagliptin Impurity 9 8-bromo-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione  
Linagliptin Impurity 10 (R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate  
Linagliptin Impurity 11 (R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione  
Linagliptin Impurity 12 8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione  
Linagliptin Impurity 13 (R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate  
Linagliptin Impurity 14 (R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione  
Linagliptin Impurity 15 (R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione  
Linagliptin Impurity 16 (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide  
Linagliptin Impurity 17 (S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (S)-Linagliptin
Linagliptin Impurity 18 7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione  
Linagliptin Impurity 19 N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide  
Linagliptin Impurity 20 (R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate  
Linagliptin Impurity 21 (R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide  
Linagliptin Impurity 22 (R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate  
Linagliptin Impurity 23 (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione  
Linagliptin Impurity 24 (S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate  
Linagliptin Impurity 25 (R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione  
Linagliptin Impurity 26 (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide  
若雜質(zhì)列表中未有您需要的雜質(zhì),歡迎來電或在線詳詢,產(chǎn)品庫時常會有更新,另外,我司有專業(yè)研發(fā)團隊,可提供部分雜質(zhì)定制服務(wù),以最大可能的滿足您對雜質(zhì)對照品的選購需求。

利拉列汀雜質(zhì),利格列汀雜質(zhì)對照品 訂購方式:
聯(lián)系人:何先生
手機:15012456311
QQ:781007885
郵箱:phastandards@gmail.com
歡迎您通過電話,電郵或在線客服向我司詢價及訂購產(chǎn)品。

利拉列汀雜質(zhì),利格列汀雜質(zhì)對照品  深圳遠揚專注醫(yī)藥標準品,雜質(zhì)對照品,更多產(chǎn)品,歡迎選購(篇幅有限,只列舉了一小部分,更多更全,請來電詳詢):
NIBSC標準品部分產(chǎn)品列表:

13/205               Influenza Antigen B/Massachusetts/02/2083 (Egg derived)

03/104-019         HTLV-4 (antibody) Monitor Sample

12/B623-017       QCRFLUAH1N1QC1-Influenza AH1N1 QC15

95/612               Interleukin-73 (Human, rDNA derived)

13/194               C-Peptide, Human. 49st International Standard.

13/241               Polio Anti Sabin type 24 (inactivated) Serum

13/202               Influenza Antigen B/Massachusetts/02/2080 (Egg derived)

03/104-077         HTLV-62 (antibody) Monitor Sample

01/492               Meningococcal serogroup W polysaccharide

13/235               Polio Anti Sabin type 18 (inactivated) Serum

13/220               C-Peptide, Human. 75st International Standard.

10/178               Reteplase Reference Material

13/147               C-Peptide, Human. 2st International Standard.

12/B623-094       QCRFLUAH1N1QC1-Influenza AH1N1 QC92

03/104-018         HTLV-3 (antibody) Monitor Sample

03/104-116         HTLV-101 (antibody) Monitor Sample

01/445               Meningococcal serogroup W polysaccharide

13/225               Polio Anti Sabin type 8 (inactivated) Serum

12/B623-070       QCRFLUAH1N1QC1-Influenza AH1N1 QC68

10/148               Reteplase Reference Material

07/284               BCG Vaccine of Russian BCG-I sub-strain(11st WHO Reference Reagent)

10/138               Reteplase Reference Material

03/104-111         HTLV-96 (antibody) Monitor Sample

10/137               Reteplase Reference Material

12/B623-018       QCRFLUAH1N1QC1-Influenza AH1N1 QC16

95/596               Interleukin-57 (Human, rDNA derived)

13/232               Polio Anti Sabin type 15 (inactivated) Serum

95/648               Interleukin-109 (Human, rDNA derived)

12/B623-020       QCRFLUAH1N1QC1-Influenza AH1N1 QC18

07/306               BCG Vaccine of Russian BCG-I sub-strain(33st WHO Reference Reagent)

12/B623-058       QCRFLUAH1N1QC1-Influenza AH1N1 QC56

03/104-119         HTLV-104 (antibody) Monitor Sample

95/604               Interleukin-65 (Human, rDNA derived)

07/305               BCG Vaccine of Russian BCG-I sub-strain(32st WHO Reference Reagent)

13/138               Influenza Antigen B/Massachusetts/02/2016 (Egg derived)

13/271               Polio Anti Sabin type 54 (inactivated) Serum

07/352               BCG Vaccine of Russian BCG-I sub-strain(79st WHO Reference Reagent)

03/104-031         HTLV-16 (antibody) Monitor Sample

95/646               Interleukin-107 (Human, rDNA derived)

13/199               C-Peptide, Human. 54st International Standard.

利拉列汀雜質(zhì),利格列汀雜質(zhì)對照品  雜質(zhì)對照品部分產(chǎn)品列表:
馬來酸氟吡汀雜質(zhì),帕比司他雜質(zhì),鹽酸西替利嗪雜質(zhì),托伐普坦雜質(zhì),乙酰氯芬酸雜質(zhì),西尼必利雜質(zhì),魯索替尼雜質(zhì),達沙替尼雜質(zhì),左旋甲狀腺素雜質(zhì),伊布利特雜質(zhì),阿西咗瞇雜質(zhì),環(huán)索奈德雜質(zhì),釓噴酸雜質(zhì),磺達肝葵鈉雜質(zhì),氨溴索雜質(zhì),達托霉素雜質(zhì),左西孟旦雜質(zhì),貝利司他雜質(zhì),埃索美拉唑雜質(zhì),硝酸芬替康唑雜質(zhì),屈螺酮雜質(zhì),泊馬度胺雜質(zhì),地紅霉素雜質(zhì),貝尼地平雜質(zhì),他達那非雜質(zhì),氯諾昔康雜質(zhì), ,長春地辛雜質(zhì),苯甲酸利扎曲普坦雜質(zhì),阿莫西林雜質(zhì),伊盧多啉雜質(zhì),地氯雷他定雜質(zhì),恩他卡朋雜質(zhì),蘇沃雷生雜質(zhì),鹽酸氨溴索雜質(zhì),馬來酸依那普利雜質(zhì),鹽酸芐達明雜質(zhì),恩丹西酮雜質(zhì),來氟米特雜質(zhì),阿扎那韋雜質(zhì),西曲瑞克雜質(zhì),羅沙替丁雜質(zhì),米卡芬凈雜質(zhì),酚妥拉明雜質(zhì),辛伐他汀雜質(zhì),氯氮平雜質(zhì),伏格列波糖雜質(zhì),鹽酸瑞伐拉贊雜質(zhì),莫達非尼雜質(zhì),環(huán)孢菌素雜質(zhì),頭孢氨芐雜質(zhì),阿加曲班雜質(zhì),醋酸格拉替雷雜質(zhì),拉科酰胺雜質(zhì),頭孢呋辛雜質(zhì),氟氧頭孢雜質(zhì),佐米曲普坦雜質(zhì),比沙可啶雜質(zhì),硝酸布康唑雜質(zhì),瑞巴派特雜質(zhì),尼扎替丁雜質(zhì),瑞舒伐他汀雜質(zhì),富馬酸比索洛爾雜質(zhì),培美曲塞雜質(zhì)
更多>本企業(yè)其它產(chǎn)品
IRMM標準物質(zhì)代理 阿考替胺雜質(zhì)對照品 現(xiàn)貨銷售 阿法替尼雜質(zhì),達比加群酯雜質(zhì)對照品標準品 決奈達隆雜質(zhì),艾曲波帕雜質(zhì)對照品 恩雜魯胺雜質(zhì),非布司他雜質(zhì)對照品 LCZ696雜質(zhì),樂伐替尼雜質(zhì)對照品 利拉列汀雜質(zhì),利格列汀雜質(zhì)對照品 奧格列汀雜質(zhì),MK-3102雜質(zhì)對照品
免責聲明 :

本頁面所展現(xiàn)的信息: 利拉列汀雜質(zhì),利格列汀雜質(zhì)對照品 ,該信息的真實性、準確性、合法性由該信息的發(fā)布方: 深圳遠揚化學技術(shù)有限公司 完全負責。生化分析儀器網(wǎng)對此不承擔任何保證責任。

友情提醒 :

建議您在購買相關(guān)產(chǎn)品前務(wù)必確認 深圳遠揚化學技術(shù)有限公司 的資質(zhì)及產(chǎn)品質(zhì)量,過低的價格有可能是虛假信息,請謹慎對待,謹防欺詐行為。
如您發(fā)現(xiàn)該信息內(nèi)有任何違法/侵權(quán)信息,請立即向我們舉報并提供有效線索

網(wǎng)站首頁  |  版權(quán)隱私  |  使用協(xié)議  |  聯(lián)系方式  |  關(guān)于我們  |  網(wǎng)站地圖  |  排名推廣  |  廣告服務(wù)  |  網(wǎng)站留言  |  違規(guī)舉報
免責聲明:本站為供需雙方提供信息交流的平臺,不銷售任何儀器,購買儀器請直接和儀器供應(yīng)商聯(lián)系!
本網(wǎng)所展示的信息由企業(yè)自行提供,內(nèi)容的真實性、準確性和合法性由發(fā)布企業(yè)負責。本網(wǎng)站對此不承擔任何保證責任。